Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
REACH authorisation expiry of five uses, granted to Octapharma AB, Produktionsgesel schaft Deutschland mbH and Octapharma S.A.S.
REACH authorisation expiry of five uses, granted to Octapharma AB, Produktionsgesel schaft Deutschland mbH and Octapharma S.A.S.
REACH authorisation expiry of three uses, granted to SEBIA
REACH authorisation expiry of one use, granted to Eli Lilly Kinsale Limited
REACH authorisation expiry of one use, granted to Sanquin Reagents B.V.
REACH authorisation expiry of one use, granted to Octapharma Pharmazeutika Produktionsgesellschaft m.b.H
The European Commission has granted 19 authorisations for uses of the following substances (review period expiry dates are in brackets): 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) 5 uses applied for by Octapharma AB and 4 other co-applicants (4 January 2033 and 4 January 2025);…